Axon Enterprise, Inc $AXON Stock Position Reduced by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc decreased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 1.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,486 shares of the biotechnology company’s stock after selling 401 shares during the quarter. Ensign Peak Advisors Inc’s holdings in Axon Enterprise were worth $26,896,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Nuveen LLC acquired a new position in Axon Enterprise in the first quarter worth $264,796,000. McElhenny Sheffield Capital Management LLC bought a new position in shares of Axon Enterprise in the 2nd quarter worth about $255,833,000. Vanguard Group Inc. boosted its holdings in shares of Axon Enterprise by 3.5% in the 2nd quarter. Vanguard Group Inc. now owns 8,937,260 shares of the biotechnology company’s stock valued at $7,399,515,000 after buying an additional 305,252 shares during the period. Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 29.8% during the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after buying an additional 212,931 shares during the last quarter. Finally, Axiom Investors LLC DE bought a new stake in shares of Axon Enterprise during the 1st quarter valued at about $93,088,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Wall Street Zen cut shares of Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. Piper Sandler lowered their price objective on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Royal Bank Of Canada initiated coverage on Axon Enterprise in a research note on Monday. They issued an “outperform” rating and a $860.00 target price on the stock. Finally, Bank of America upped their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $814.00.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the transaction, the chief financial officer directly owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 100 shares of the business’s stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $752.54, for a total value of $75,254.00. Following the completion of the sale, the director directly owned 1,416 shares in the company, valued at $1,065,596.64. This represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 38,622 shares of company stock valued at $26,439,364. Insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Up 0.5%

NASDAQ:AXON opened at $521.99 on Friday. Axon Enterprise, Inc has a 1 year low of $469.24 and a 1 year high of $885.91. The business has a fifty day moving average of $681.33 and a 200-day moving average of $731.06. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The stock has a market cap of $41.19 billion, a price-to-earnings ratio of 128.89, a PEG ratio of 29.49 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). The company had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s revenue for the quarter was up 30.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.45 EPS. Equities analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.